chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: had metallic taste in mouth; where they gave the vaccine was really painful; This spontaneous case was reported by a patient and describes the occurrence of DYSGEUSIA (had metallic taste in mouth) and VACCINATION SITE PAIN (where they gave the vaccine was really painful) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Gastroenteritis.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DYSGEUSIA (had metallic taste in mouth) and VACCINATION SITE PAIN (where they gave the vaccine was really painful). On 20-Jan-2021, DYSGEUSIA (had metallic taste in mouth) had resolved. On 22-Jan-2021, VACCINATION SITE PAIN (where they gave the vaccine was really painful) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included an unspecified medication used for gastroenteritis.   The patient used ice for treatment of the vaccination site pain.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: tenderness in the arm is not resolving; Swollen; Prolonged swelling of the lymph nodes in the vaccination arm; Chills; body aches; fever; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness in the arm is not resolving) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm). On an unknown date, the patient experienced CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen) had not resolved and CHILLS (Chills), MYALGIA (body aches) and PYREXIA (fever) had resolved. Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No laboratory details was given.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up contain no new information please to confirm NNI
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: tenderness in the arm is not resolving; Swollen; Prolonged swelling of the lymph nodes in the vaccination arm; Chills; body aches; fever; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever) and VACCINATION SITE PAIN (tenderness in the arm is not resolving) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm). On an unknown date, the patient experienced CHILLS (Chills), MYALGIA (body aches), PYREXIA (fever), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen). The patient was treated with NAPROXEN at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Prolonged swelling of the lymph nodes in the vaccination arm), VACCINATION SITE PAIN (tenderness in the arm is not resolving) and VACCINATION SITE SWELLING (Swollen) had not resolved and CHILLS (Chills), MYALGIA (body aches) and PYREXIA (fever) had resolved. Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No laboratory details was given.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up contain no new information please to confirm NNI
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Developed the Covid virus; cough; trouble breathing; Itchy; Sneezing; Runny nose; Diarrhea; 100.4 fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy) and SNEEZING (Sneezing) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), DIARRHOEA (Diarrhea) and PYREXIA (100.4 fever). On 17-Jan-2021, PYREXIA (100.4 fever) had resolved. At the time of the report, COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and DIARRHOEA (Diarrhea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.4 (High) for two days over the weekend. On 16-Jan-2021, Oxygen saturation: 98-100 normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included an unspecified birth control pill.   The patient took Allegra and Motrin for treatment of the events.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation, Pruritus, Pyrexia, Rhinorrhoea, Sneezing
Clinical narrative: Developed the Covid virus; cough; trouble breathing; Itchy; Sneezing; Runny nose; Diarrhea; 100.4 fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy) and SNEEZING (Sneezing) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), DIARRHOEA (Diarrhea) and PYREXIA (100.4 fever). On 17-Jan-2021, PYREXIA (100.4 fever) had resolved. At the time of the report, COVID-19 (Developed the Covid virus), COUGH (cough), DYSPNOEA (trouble breathing), PRURITUS (Itchy), SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and DIARRHOEA (Diarrhea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 100.4 (High) for two days over the weekend. On 16-Jan-2021, Oxygen saturation: 98-100 normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included an unspecified birth control pill.   The patient took Allegra and Motrin for treatment of the events.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Hypersomnia, Lethargy, Malaise, Pregnancy test
Clinical narrative: Felt very sleepy; Lethargy; Did not feel good at all.; Reaction at the injection site; Pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) in a 38-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Dec-2020 and the estimated date of delivery was 29-Sep-2021. On 11-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 11-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, LETHARGY (lethargy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) outcome was unknown and HYPERSOMNIA (Felt very sleepy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound foetal: heartbeats detected (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient took Tylenol for the treatment of the events.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: Updated IRD for the case.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound foetal, Vaccination site reaction
Clinical narrative: Felt very sleepy; Lethargy; Did not feel good at all.; Reaction at the injection site; Pregnant; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant), LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) in a 38-year-old female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Dec-2020 and the estimated date of delivery was 29-Sep-2021. On 11-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced LETHARGY (lethargy), HYPERSOMNIA (Felt very sleepy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 11-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, LETHARGY (lethargy), MALAISE (Did not feel good at all.) and VACCINATION SITE REACTION (Reaction at the injection site) outcome was unknown and HYPERSOMNIA (Felt very sleepy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound foetal: heartbeats detected (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   The patient took Tylenol for the treatment of the events.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: Updated IRD for the case.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Weak; Real tired and sleepy/exhausted; I could hardly breathe; Dizzy; This spontaneous case was reported by a patient and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included Asthma (Patient has a history of asthma but not had asthma or breathing problems since1987 due to keeping it under control).    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form as required.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information also mentioned an inhaler for treatment of the events.  Patient mentioned having a prior anaphylactic shock from an allergy shot much before and was cautious with this vaccine due to that.    Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional information added on 25JUN2021 is non significant. Patient updated email ID.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: anxious; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (anxious) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (anxious). At the time of the report, ANXIETY (anxious) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's concomitant medications included unspecified medication for diabetes.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dizziness
Clinical narrative: Weakness; Dizziness; anxious; This spontaneous case was reported by a patient and describes the occurrence of ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD, Emphysema and Reye's syndrome. Previously administered products included for Product used for unknown indication: Flu shot (Previously he had worse reaction to Flu shot). Past adverse reactions to the above products included Adverse reaction with Flu shot.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious). At the time of the report, ASTHENIA (Weakness), DIZZINESS (Dizziness) and ANXIETY (anxious) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Glucose tolerance test normal, Malaise, Maternal exposure during pregnancy, Pregnancy test, Ultrasound abdomen
Clinical narrative: Since having my vaccine I have developed a horrible; Pregnant; This spontaneous retrospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and MALAISE (Since having my vaccine I have developed a horrible) in a 30-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-May-2020 and the estimated date of delivery was 25-Feb-2021. On 19-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 30-May-2021, the patient experienced MALAISE (Since having my vaccine I have developed a horrible). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-seventh week of the pregnancy. The delivery occurred  on 29-Jan-2021, which was reported as Full-term. For neonate 1, The outcome was reported as Delivered NOS. On 19-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, MALAISE (Since having my vaccine I have developed a horrible) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2020, Pregnancy test: positive (Positive) Positive. In November 2020, Glucose tolerance test normal: (normal) Normal. In November 2020, Ultrasound abdomen: normal (normal) Normal. In December 2020, Glucose tolerance test normal: (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: Follow-up information received on 31-may-2021. Added a event,Since having my vaccine I have developed a horrible.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: half of the upper arm was red; slightly elevated skin; arm that got the injection started itching; delayed skin rash at the injection site; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to sween cream) and Penicillin allergy.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (half of the upper arm was red), VACCINATION SITE SWELLING (slightly elevated skin), VACCINATION SITE PRURITUS (arm that got the injection started itching) and VACCINATION SITE RASH (delayed skin rash at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-077736 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI On 25-May-2021: NNI; Sender's Comments: Based on the current available information and the temporal association between the use of the product and the start date of the event, a casual relationship cannot be excluded.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: infected with COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (infected with COVID 19) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced COVID-19 (infected with COVID 19). At the time of the report, COVID-19 (infected with COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Significant follow up received - Patient demographics, suspect product details and event details were updated.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, SARS-CoV-2 test
Clinical narrative: She became symptomatic for covid 1/8/21 and tested positive 1/11/21.; Slight occasional cough; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.) and COUGH (Slight occasional cough) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included DVT of calf (~35 years ago). Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL and VERAPAMIL HYDROCHLORIDE (CALAN [VERAPAMIL HYDROCHLORIDE]) for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced COUGH (Slight occasional cough). On 11-Jan-2021, the patient experienced COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE (DELSYM) for COVID-19 and Cough, at a dose of UNK dosage form. At the time of the report, COVID-19 (She became symptomatic for covid 1/8/21 and tested positive 1/11/21.) and COUGH (Slight occasional cough) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is improving well so far, and is afebrile.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: infected with COVID 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (infected with COVID 19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On 31-Dec-2020, the patient experienced COVID-19 (infected with COVID 19). At the time of the report, COVID-19 (infected with COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided by the reporter. No treatment medication was provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sinusitis
Clinical narrative: sinus infection; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form; DOXYCYCLINE on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form; MONTELUKAST on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form and ATORVASTATIN CALCIUM (AVASTIN [ATORVASTATIN CALCIUM]) (nasal) on 18-Jan-2021 for Sinus infection and Fever, at a dose of UNK dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    This case was linked to MOD-2021-012744 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Pain in extremity, Vaccination site erythema, Vaccination site induration
Clinical narrative: Arm hurting; hard at the injection stie; hurt under her arm; arm red at the injection site; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurting). At the time of the report, PAIN IN EXTREMITY (Arm hurting), VACCINATION SITE INDURATION (hard at the injection stie), AXILLARY PAIN (hurt under her arm) and VACCINATION SITE ERYTHEMA (arm red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Diarrhoea, Dizziness, Eating disorder, Nausea
Clinical narrative: Can't eat anything; Anxious; dizziness; Nauseous; fever; diarrhea; Achiness all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and PAIN (Achiness all over body) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever). On 17-Jan-2021, the patient experienced EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous). On 15-Jan-2021, DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever) had resolved. At the time of the report, EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Can't eat anything; Anxious; dizziness; Nauseous; fever; diarrhea; Achiness all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and PAIN (Achiness all over body) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever). On 17-Jan-2021, the patient experienced EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous). On 15-Jan-2021, DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever) had resolved. At the time of the report, EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over my back; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rash all over my back) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced RASH (Rash all over my back). On 17-Jan-2021, RASH (Rash all over my back) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Musculoskeletal stiffness, Neck pain, Pain in extremity, Vaccination site erythema
Clinical narrative: Stiff neck; baseball size lump; hard, hot, red baseball size lump; Itching at the site; red baseball size lump; hot; Arm mildly sore; Neck pain; Back pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic back pain and Neck pain.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain) and BACK PAIN (Back pain). On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). At the time of the report, PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-077018 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: The patient details, vaccine information and event outcome were updated.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Stiff neck; baseball size lump; hard, hot, red baseball size lump; Itching at the site; red baseball size lump; hot; Arm mildly sore; Neck pain; Back pain; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic back pain and Neck pain.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain) and BACK PAIN (Back pain). On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). At the time of the report, PAIN IN EXTREMITY (Arm mildly sore), NECK PAIN (Neck pain), BACK PAIN (Back pain), VACCINATION SITE WARMTH (hot), MUSCULOSKELETAL STIFFNESS (Stiff neck), VACCINATION SITE MASS (baseball size lump), VACCINATION SITE INDURATION (hard, hot, red baseball size lump), VACCINATION SITE PRURITUS (Itching at the site) and VACCINATION SITE ERYTHEMA (red baseball size lump) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.    This case was linked to MOD-2021-077018 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: The patient details, vaccine information and event outcome were updated.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site swelling, Sinusitis
Clinical narrative: Sinusitis; Swelling at injection site; This spontaneous case was reported by a patient and describes the occurrence of SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L204) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site). The patient was treated with LEVOTHYROXINE SODIUM (SYNTHROID) at a dose of UNK dosage form; ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) at a dose of UNK dosage form and LISINOPRIL at a dose of UNK dosage form. At the time of the report, SINUSITIS (Sinusitis) and INJECTION SITE SWELLING (Swelling at injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event following immunisation
Clinical narrative: Adverse event following immunisation; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (Side Effects) outcome was unknown. Not Provided   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No concomitant medications were reported.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash at injection site; itchiness at the site of reaction; Redness at site of injection; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the site of reaction), VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE RASH (Rash at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the site of reaction) and VACCINATION SITE ERYTHEMA (Redness at site of injection). On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the site of reaction), VACCINATION SITE ERYTHEMA (Redness at site of injection) and VACCINATION SITE RASH (Rash at injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  As per the reported follow-up, "the rash she experienced came about 2 weeks after her first vaccine and went away after no more than 3 days as I remember." The reporter considered the patient's reaction as minor and the patient did not seek any medical attention. The patient received the second vaccine dose on an unspecified date and "had no problem."   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Updated outcomes of events to recovered/resolved, dose 2 regimen added, reporter's first name corrected, action taken updated
Sex: M
Vaccine: COVID19
Symptoms: Intentional product use issue, SARS-CoV-2 test
Clinical narrative: he was unable to receive his second vaccine as scheduled; This spontaneous case was reported by a health care professional and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (he was unable to receive his second vaccine as scheduled) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2020, SARS-CoV-2 test: positive (Positive) COVID Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment included Dsansone was noted.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Lab data added were added.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Defaecation disorder, Feeling abnormal, Headache, Influenza like illness
Clinical narrative: Feels so bad, I was in a fog; my bowels wanted to move, but wouldn't move; fluish; moaning; Shaking; throwing up all over the place; banging headache; had chills that she was shaking; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning) and TREMOR (Shaking) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M012120N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 01-Nov-2020.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of UNK dosage form. On 22-Jan-2021, INFLUENZA LIKE ILLNESS (fluish) had resolved. At the time of the report, FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient reported that she felt much better on 23 Jan 2021.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No new significant information was provided. The reporter's email I address was updated.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Moaning, Tremor, Vomiting
Clinical narrative: Feels so bad, I was in a fog; my bowels wanted to move, but wouldn't move; fluish; moaning; Shaking; throwing up all over the place; banging headache; had chills that she was shaking; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning) and TREMOR (Shaking) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M012120N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 01-Nov-2020.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of UNK dosage form. On 22-Jan-2021, INFLUENZA LIKE ILLNESS (fluish) had resolved. At the time of the report, FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient reported that she felt much better on 23 Jan 2021.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No new significant information was provided. The reporter's email I address was updated.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Vaccination site pain
Clinical narrative: Pregnant; Soreness in arm; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and VACCINATION SITE PAIN (Soreness in arm) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included Gestational diabetes (Maternal medical history includes gestational diabetes) in April 2017. Concurrent medical conditions included Allergy (Seasonal Allergies).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 03-Jan-2021 and the estimated date of delivery was 10-Oct-2021. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm). On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  first week of the pregnancy.  On 14-Jan-2021, VACCINATION SITE PAIN (Soreness in arm) had resolved. On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Pregnancy test: positive Positive.         Patient previously had live full term child birth.  The patient's estimated date of conception was 17-JAN-2021  No concomitant medications were reported.   No treatment information was provided/